Ranbaxy Laboratories Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
-
|
P/BV
|
-
|
Book Value (Rs.)
|
-
|
52 Week High/Low (Rs.)
|
-
|
FV/ML
|
-
|
P/E(X)
|
-
|
Bookclosure
|
-
|
EPS (Rs.)
|
-
|
Div Yield (%)
|
-
|
|
(Rs. in Crs.)
Months | 15 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 |
| | | |
Net Profit/Loss Before Extraordinary Items And Tax | -741.76 | 1244.89 | -2686.48 |
| | | |
Net CashFlow From Operating Activities | -3562.40 | 1582.10 | 638.81 |
Net Cash Used In Investing Activities | 1831.97 | -1820.32 | 1668.71 |
Net Cash Used From Financing Activities | 1016.16 | 236.92 | -1217.67 |
Foreign Exchange Gains / Losses | 126.17 | -50.96 | 111.90 |
| | | |
Net Inc/Dec In Cash And Cash Equivalents | -588.10 | -52.25 | 1201.75 |
Cash And Cash Equivalents Begin of Year | 1830.71 | 1882.96 | 681.21 |
Cash And Cash Equivalents End Of Year | 1242.61 | 1830.71 | 1882.96 |